KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Non Operating Income (2016 - 2025)

Gilead Sciences (GILD) has disclosed Non Operating Income for 17 consecutive years, with $349.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 1069.44% year-over-year to $349.0 million, compared with a TTM value of $798.0 million through Dec 2025, up 13200.0%, and an annual FY2025 reading of $798.0 million, up 13200.0% over the prior year.
  • Non Operating Income was $349.0 million for Q4 2025 at Gilead Sciences, down from $569.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $569.0 million in Q3 2025 and bottomed at -$369.0 million in Q1 2021.
  • Average Non Operating Income over 5 years is -$9.3 million, with a median of -$38.5 million recorded in 2023.
  • The sharpest move saw Non Operating Income soared 3030.0% in 2023, then plummeted 460.44% in 2025.
  • Year by year, Non Operating Income stood at $57.0 million in 2021, then plummeted by 117.54% to -$10.0 million in 2022, then skyrocketed by 3030.0% to $293.0 million in 2023, then tumbled by 112.29% to -$36.0 million in 2024, then skyrocketed by 1069.44% to $349.0 million in 2025.
  • Business Quant data shows Non Operating Income for GILD at $349.0 million in Q4 2025, $569.0 million in Q3 2025, and $208.0 million in Q2 2025.